Global Ursodeoxycholic Acid Drug Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Ursodeoxycholic Acid Drug market size will reach 1,396.44 Million USD in 2025 and is projected to reach 1,761.10 Million USD by 2032, with a CAGR of 3.37% (2025-2032). Notably, the China Ursodeoxycholic Acid Drug market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Ursodeoxycholic Acid (UDCA) as a drug refers to the medication containing the active pharmaceutical ingredient ursodeoxycholic acid. This bile acid is used therapeutically for its ability to dissolve cholesterol-based gallstones, preventing their formation and promoting their elimination. Additionally, Ursodeoxycholic Acid is employed in the treatment of certain liver conditions, including primary biliary cholangitis, where it exhibits hepatoprotective effects. The drug is typically administered orally, commonly in the form of tablets or capsules, and its use is directed by healthcare professionals based on the specific medical condition being addressed. Ursodeoxycholic Acid plays a vital role in managing gallstone-related issues and liver disorders, offering a pharmacological approach to improve patient outcomes.
The major global manufacturers of Ursodeoxycholic Acid Drug include Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, Humanwell, Mitsubishi Tanabe Pharma, Lannett, Mylan, Bruschettini, Impax, Shanghai Pharma, Grindeks, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Ursodeoxycholic Acid Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Ursodeoxycholic Acid Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Ursodeoxycholic Acid Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Ursodeoxycholic Acid Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Ursodeoxycholic Acid Drug Include:
Dr. Falk Pharma
Daewoong Pharmaceutical
Teva
Humanwell
Mitsubishi Tanabe Pharma
Lannett
Mylan
Bruschettini
Impax
Shanghai Pharma
Grindeks
Ursodeoxycholic Acid Drug Product Segment Include:
Capsule Drug
Tablet Drug
Ursodeoxycholic Acid Drug Product Application Include:
Primary Biliary Cirrhosis(PBC)
Gallstones
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Ursodeoxycholic Acid Drug Industry PESTEL Analysis
Chapter 3: Global Ursodeoxycholic Acid Drug Industry Porter's Five Forces Analysis
Chapter 4: Global Ursodeoxycholic Acid Drug Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Ursodeoxycholic Acid Drug Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Ursodeoxycholic Acid Drug Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Ursodeoxycholic Acid Drug Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Ursodeoxycholic Acid Drug market size will reach 1,396.44 Million USD in 2025 and is projected to reach 1,761.10 Million USD by 2032, with a CAGR of 3.37% (2025-2032). Notably, the China Ursodeoxycholic Acid Drug market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Ursodeoxycholic Acid (UDCA) as a drug refers to the medication containing the active pharmaceutical ingredient ursodeoxycholic acid. This bile acid is used therapeutically for its ability to dissolve cholesterol-based gallstones, preventing their formation and promoting their elimination. Additionally, Ursodeoxycholic Acid is employed in the treatment of certain liver conditions, including primary biliary cholangitis, where it exhibits hepatoprotective effects. The drug is typically administered orally, commonly in the form of tablets or capsules, and its use is directed by healthcare professionals based on the specific medical condition being addressed. Ursodeoxycholic Acid plays a vital role in managing gallstone-related issues and liver disorders, offering a pharmacological approach to improve patient outcomes.
The major global manufacturers of Ursodeoxycholic Acid Drug include Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, Humanwell, Mitsubishi Tanabe Pharma, Lannett, Mylan, Bruschettini, Impax, Shanghai Pharma, Grindeks, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Ursodeoxycholic Acid Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Ursodeoxycholic Acid Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Ursodeoxycholic Acid Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Ursodeoxycholic Acid Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Ursodeoxycholic Acid Drug Include:
Dr. Falk Pharma
Daewoong Pharmaceutical
Teva
Humanwell
Mitsubishi Tanabe Pharma
Lannett
Mylan
Bruschettini
Impax
Shanghai Pharma
Grindeks
Ursodeoxycholic Acid Drug Product Segment Include:
Capsule Drug
Tablet Drug
Ursodeoxycholic Acid Drug Product Application Include:
Primary Biliary Cirrhosis(PBC)
Gallstones
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Ursodeoxycholic Acid Drug Industry PESTEL Analysis
Chapter 3: Global Ursodeoxycholic Acid Drug Industry Porter's Five Forces Analysis
Chapter 4: Global Ursodeoxycholic Acid Drug Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Ursodeoxycholic Acid Drug Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Ursodeoxycholic Acid Drug Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Ursodeoxycholic Acid Drug Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Ursodeoxycholic Acid Drug Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Ursodeoxycholic Acid Drug Product by Type
- 1.2.1 Capsule Drug
- 1.2.2 Tablet Drug
- 1.3 Ursodeoxycholic Acid Drug Product by Application
- 1.3.1 Primary Biliary Cirrhosis(PBC)
- 1.3.2 Gallstones
- 1.3.3 Others
- 1.4 Global Ursodeoxycholic Acid Drug Market Revenue and Sales Analysis
- 1.4.1 Global Ursodeoxycholic Acid Drug Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Ursodeoxycholic Acid Drug Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Ursodeoxycholic Acid Drug Market Sales Price Trend Analysis (2020-2032)
- 1.5 Ursodeoxycholic Acid Drug Market Development Status and Trends
- 1.5.1 Ursodeoxycholic Acid Drug Industry Development Status Analysis
- 1.5.2 Ursodeoxycholic Acid Drug Industry Development Trends Analysis
- 2 Ursodeoxycholic Acid Drug Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Ursodeoxycholic Acid Drug Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Ursodeoxycholic Acid Drug Market Analysis by Country
- 4.1 Global Ursodeoxycholic Acid Drug Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Ursodeoxycholic Acid Drug Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Ursodeoxycholic Acid Drug Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Ursodeoxycholic Acid Drug Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Ursodeoxycholic Acid Drug Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Ursodeoxycholic Acid Drug Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Ursodeoxycholic Acid Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Ursodeoxycholic Acid Drug Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Ursodeoxycholic Acid Drug Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Ursodeoxycholic Acid Drug Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Ursodeoxycholic Acid Drug Average Sales Price by Manufacturers (2021-2025)
- 5.2 Ursodeoxycholic Acid Drug Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Ursodeoxycholic Acid Drug Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Ursodeoxycholic Acid Drug Market Analysis by Type
- 6.1 Global Ursodeoxycholic Acid Drug Market Revenue Analysis by Type
- 6.1.1 Global Ursodeoxycholic Acid Drug Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Ursodeoxycholic Acid Drug Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Ursodeoxycholic Acid Drug Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Ursodeoxycholic Acid Drug Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Dr. Falk Pharma
- 7.1.1 Dr. Falk Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Dr. Falk Pharma Ursodeoxycholic Acid Drug Product Portfolio
- 7.1.3 Dr. Falk Pharma Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Daewoong Pharmaceutical
- 7.2.1 Daewoong Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Product Portfolio
- 7.2.3 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Teva
- 7.3.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Teva Ursodeoxycholic Acid Drug Product Portfolio
- 7.3.3 Teva Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Humanwell
- 7.4.1 Humanwell Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Humanwell Ursodeoxycholic Acid Drug Product Portfolio
- 7.4.3 Humanwell Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Mitsubishi Tanabe Pharma
- 7.5.1 Mitsubishi Tanabe Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Product Portfolio
- 7.5.3 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Lannett
- 7.6.1 Lannett Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Lannett Ursodeoxycholic Acid Drug Product Portfolio
- 7.6.3 Lannett Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Mylan
- 7.7.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Mylan Ursodeoxycholic Acid Drug Product Portfolio
- 7.7.3 Mylan Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Bruschettini
- 7.8.1 Bruschettini Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Bruschettini Ursodeoxycholic Acid Drug Product Portfolio
- 7.8.3 Bruschettini Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Impax
- 7.9.1 Impax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Impax Ursodeoxycholic Acid Drug Product Portfolio
- 7.9.3 Impax Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Shanghai Pharma
- 7.10.1 Shanghai Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Shanghai Pharma Ursodeoxycholic Acid Drug Product Portfolio
- 7.10.3 Shanghai Pharma Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 Grindeks
- 7.11.1 Grindeks Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Grindeks Ursodeoxycholic Acid Drug Product Portfolio
- 7.11.3 Grindeks Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Ursodeoxycholic Acid Drug Industry Chain Analysis
- 8.2 Ursodeoxycholic Acid Drug Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Ursodeoxycholic Acid Drug Product Downstream Application Analysis
- 8.3.1 Global Ursodeoxycholic Acid Drug Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Ursodeoxycholic Acid Drug Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Ursodeoxycholic Acid Drug Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Ursodeoxycholic Acid Drug Typical Downstream Customers
- 8.5 Ursodeoxycholic Acid Drug Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
